IN187379B - - Google Patents

Info

Publication number
IN187379B
IN187379B IN792DE1996A IN187379B IN 187379 B IN187379 B IN 187379B IN 792DE1996 A IN792DE1996 A IN 792DE1996A IN 187379 B IN187379 B IN 187379B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to IN792DE1996 priority Critical patent/IN187379B/en
Priority to US08/824,409 priority patent/US5876751A/en
Priority to CN97104932A priority patent/CN1099285C/zh
Priority to AU17861/97A priority patent/AU695642B2/en
Priority to CA002202425A priority patent/CA2202425A1/fr
Priority to NZ314584A priority patent/NZ314584A/en
Priority to KR1019970013351A priority patent/KR970069035A/ko
Priority to JP09550097A priority patent/JP3150642B2/ja
Priority to TW086115420A priority patent/TW491702B/zh
Priority to IN289DE2000 priority patent/IN187310B/en
Publication of IN187379B publication Critical patent/IN187379B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN792DE1996 1996-04-12 1996-04-12 IN187379B (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN792DE1996 IN187379B (fr) 1996-04-12 1996-04-12
US08/824,409 US5876751A (en) 1996-04-12 1997-03-26 Antispasmodic and antinflammatory composition and a process for the manufacture thereof
CN97104932A CN1099285C (zh) 1996-04-12 1997-03-26 新的镇痉剂和消炎药的组合物及其制造方法
AU17861/97A AU695642B2 (en) 1996-04-12 1997-04-11 A novel antispasmodic and antinflammatory composition and a process for the manufacture thereof
CA002202425A CA2202425A1 (fr) 1996-04-12 1997-04-11 Nouvelle composition anti-spasmodique et anti-inflammatoire et procede de fabrication de cette derniere
NZ314584A NZ314584A (en) 1996-04-12 1997-04-11 Antispasmodic composition containing a non steroidal anti inflammatory drug such as diclofenac or nimesulide, pitofenone hydrochloride and fenpiverinium bromide
KR1019970013351A KR970069035A (ko) 1996-04-12 1997-04-11 새로운 진경제와 소염제의 합성 및 제조방법
JP09550097A JP3150642B2 (ja) 1996-04-12 1997-04-14 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
TW086115420A TW491702B (en) 1996-04-12 1997-10-20 A novel antispasmodic and antiinflammatory composition and a process for the manufacture thereof
IN289DE2000 IN187310B (fr) 1996-04-12 2000-03-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN792DE1996 IN187379B (fr) 1996-04-12 1996-04-12

Publications (1)

Publication Number Publication Date
IN187379B true IN187379B (fr) 2002-04-13

Family

ID=11091259

Family Applications (2)

Application Number Title Priority Date Filing Date
IN792DE1996 IN187379B (fr) 1996-04-12 1996-04-12
IN289DE2000 IN187310B (fr) 1996-04-12 2000-03-22

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN289DE2000 IN187310B (fr) 1996-04-12 2000-03-22

Country Status (9)

Country Link
US (1) US5876751A (fr)
JP (1) JP3150642B2 (fr)
KR (1) KR970069035A (fr)
CN (1) CN1099285C (fr)
AU (1) AU695642B2 (fr)
CA (1) CA2202425A1 (fr)
IN (2) IN187379B (fr)
NZ (1) NZ314584A (fr)
TW (1) TW491702B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1954A (en) * 1999-09-28 2009-02-10 Panacea Biotec Ltd Controlled release compositions comprising nimesulide.
WO2005027879A1 (fr) * 2003-09-24 2005-03-31 Novartis Consumer Health S.A. Comprimes revetus
CN106580886A (zh) * 2016-12-05 2017-04-26 北京万全德众医药生物技术有限公司 一种双氯芬酸钾散剂及其制备方法
JP7025129B2 (ja) * 2017-05-17 2022-02-24 小林製薬株式会社 筋痙攣治療剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA261585A (fr) * 1926-06-08 P. Gail John Matelas
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
FR2638970A1 (fr) * 1988-11-16 1990-05-18 Corbiere Jerome Nouvelles compositions pharmaceutiques agissant sur la presbytie et leur procede d'obtention
KR920002149A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 장애 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
WO1993000895A1 (fr) * 1991-07-04 1993-01-21 Taisho Pharmaceutical Co., Ltd. Analgesique

Also Published As

Publication number Publication date
US5876751A (en) 1999-03-02
IN187310B (fr) 2002-03-23
TW491702B (en) 2002-06-21
AU695642B2 (en) 1998-08-20
JP3150642B2 (ja) 2001-03-26
NZ314584A (en) 1998-05-27
JPH1036258A (ja) 1998-02-10
AU1786197A (en) 1998-01-08
KR970069035A (ko) 1997-11-07
CN1218692A (zh) 1999-06-09
CN1099285C (zh) 2003-01-22
CA2202425A1 (fr) 1997-10-12

Similar Documents

Publication Publication Date Title
IN183120B (fr)
IN189978B (fr)
ITMI960153A0 (fr)
IN187379B (fr)
ITMC960003A0 (fr)
ITMC960061A0 (fr)
ITMC960038A0 (fr)
IN181809B (fr)
ITMI960418A0 (fr)
ITMI960546V0 (fr)
ITMC960055A0 (fr)
ITMI960119A0 (fr)
ITFI960046A0 (fr)
ITCT960018A0 (fr)
CN3045853S (fr)
CN3042289S (fr)
CN3045530S (fr)
CN3045208S (fr)
CN3047493S (fr)
CN3044349S (fr)
CN3047348S (fr)
CN3044348S (fr)
CN3044347S (fr)
CN3045806S (fr)
CN3044168S (fr)